Pfizer launches Rimegepant in Singapore for Acute and Prophylactic Migraine relief

Pfizer’s NURTEC® (rimegepant), an orally disintegrating tablet for both the acute treatment of migraine is now...

January 31, 2024 | Wednesday | News
Junshi Biosciences, Dr. Reddy’s to develop and commercialise oncology drug in 21 countries

Shanghai Junshi Biosciences Co. has collaborated with Indian pharmaceutical firm Dr. Reddy’s Laboratories to devel...

May 8, 2023 | Monday | News
Monoclonal antibody drug by GSK Singapore approved to treat chronic rhinosinusitis

GSK Singapore announced that Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5...

February 7, 2023 | Tuesday | News
China approves first and only therapy available for patients with EGFR Exon20 Insertion+ NSCLC

Japan headquatered Takeda's EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (N...

January 12, 2023 | Thursday | News
Diabetic neuropathic pain field presents significant opportunity for drug developers, says GlobalData

The current diabetic neuropathic pain treatment paradigm includes many established analgesics that provide sym...

December 20, 2022 | Tuesday | Analysis
Singapore paves the way for improved treatment of Alzheimer’s disease

A major clinical trial of an antibody treatment may soon pave the way for improved treatment of Alzheimer’s diseas...

December 6, 2022 | Tuesday | News
Huadong becomes strategic partner in Asia for Heidelberg Pharma, strikes deal worth $0.9B

German firm Heidelberg Pharma AG and Huadong Medicine in China have entered into a strategic partner...

March 1, 2022 | Tuesday | News
Japan to commercialize next-gen Hunter Syndrome therapy

Japanese firms Takeda Pharmaceutical Company and JCR Pharmaceuticals have announced a geographically-focused exclusive c...

October 1, 2021 | Friday | News
US approves first ophthalmology biosimilar, developed by South Korea

South Korea-based Samsung Bioepis has announced that the US Food and Drug Administration (FDA) has approved BYOOVIZ...

September 23, 2021 | Thursday | News
Japan sets eyes on rare pediatric liver diseases

US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...

September 22, 2021 | Wednesday | News
Australia approves novel therapy to treat Advanced Small Cell Lung Cancer

Australian patients with an aggressive form of lung cancer (metastatic Small Cell Lung Cancer) can now access a new...

September 15, 2021 | Wednesday | News
Eli Lilly Japan, Daiichi Sankyo ink pact to commercialise migraine drug

Eli Lilly Japan and Daiichi Sankyo Company have concluded an agreement on commercialisation collaboration in Japan for t...

September 1, 2021 | Wednesday | News
Japan to distribute hyperuricemia drug in five ASEAN countries

Japan-based Eisai and FUJI YAKUHIN have inked a license agreement concerning dotinurad (generic name), a treatment for h...

August 31, 2021 | Tuesday | News
Menarini to commercialize Japanese drug in Singapore, Malaysia, and the Philippines

Singapore-based Menarini Asia-Pacific Holdings, a part of the leading Italian global biopharmaceutical company Menarini ...

August 23, 2021 | Monday | News
UK's NICE recommends abemaciclib for advanced breast cancer

The UK National Institute for Health and Care Excellence (NICE) has published new draft guidance which recommends Eli Li...

August 13, 2021 | Friday | News
FDA approves combination therapy for Advanced Renal Cell Carcinoma (RCC)

U.S. Food and Drug Administration (FDA) has approved a combination therapy from Eisai and Merck (MSD) namely,&...

August 12, 2021 | Thursday | News
Yuyu Pharma to distribute Novartis Korea's prescription medicines

Yuyu Pharma and Novartis Korea have entered into an agreement in which Yuyu will have exclusive distribution rights for ...

August 4, 2021 | Wednesday | News
FDA approves Medtronic's Artificial Intelligence Algorithms for Cardiac Monitoring

Medtronic, (headquartered in Dublin, Ireland), the global leader in medical technology, announced U.S. Food and Dru...

July 29, 2021 | Thursday | News